Glorincor Pharmaceuticals
TIN 7705899855, PSRN 1097746627395

The Glorinkor company was founded in 2009 in Moscow as a consulting center to support foreign companies interested in investing in the Russian economy and developing business in the post-Soviet space. In 2015, GLORINCOR LLC was established in the Republic of Belarus to accompany foreign investors in various industries. As a result, the choice was made to accompany high-tech companies from the healthcare industry. In 2017, agreements were signed with leading Asian biopharmaceutical companies on the registration and localization of biological and generic medicines in the field of treatment of oncological, endocrinological and autoimmune diseases. The list of medicines and health products is expanding and includes medicines of various pharmacotherapeutic groups, including drugs for the treatment of cardiovascular, infectious and neurological diseases. In 2022, Glorincor signed agreements on the registration and localization of vaccines for the immunization of children against diphtheria, tetanus, pertussis, hepatitis B, hemophilic infection type b.